
Suncross Pharmaceuticals Private Limited
About Suncross Pharmaceuticals Private Limited
Data last updated:
Suncross Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It was incorporated on 29 May 2023.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U46497MP2023PTC065990. Its GSTIN is 23ABKCS9344R1ZG (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Indresh Kumar Gupta and Shiv Shankar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.88 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹38,090 (net margin 2.6%) and EBITDA of ₹49,219 (EBITDA margin 3.3%).
Company details
Contact details
Suncross Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered AddressPlot No. 101 Second Floor Flat No 201, Limbodi, Indore, Madhya Pradesh, India – 452001
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Suncross Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Suncross Pharmaceuticals Private Limited, buy the company report.
Financials of Suncross Pharmaceuticals Private Limited
FY 2025 filings availableSuncross Pharmaceuticals Private Limited reported revenue of ₹14.88 Lakh (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 17% in the latest year. EBITDA rose 35% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹49,219 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹38,090 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.3% | |
| Net Profit Margin | 2.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Suncross Pharmaceuticals Private Limited, buy the company report.
Board of directors of Suncross Pharmaceuticals Private Limited
Suncross Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indresh Kumar Gupta | Director | 29 May 2023 | 3 Years 5 Months | Current |
| Shiv Shankar Gupta | Additional Director | 28 Aug 2025 | 1 Years 2 Months | Current |
| Poornima Dwivedi | Additional Director | 28 Aug 2025 | 1 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Suncross Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suncross Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Suncross Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23ABKCS9344R1ZG | Madhya Pradesh | Active | 05 Jul 2023 |
To see the full GST registrations and return filing status of Suncross Pharmaceuticals Private Limited, buy the company report.
Recent activity
Suncross Pharmaceuticals Private Limited has 6 board changes on record since 2023: 4 appointments and 2 cessations. The latest: Poornima Dwivedi was appointed as Additional Director on 28 Aug 2025.
Frequently asked questions
Suncross Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. It was incorporated on 29 May 2023 (3+ years old) and is registered under CIN U46497MP2023PTC065990.
Suncross Pharmaceuticals has 3 current directors:
- Indresh Kumar Gupta - Director
- Shiv Shankar Gupta - Additional Director
- Poornima Dwivedi - Additional Director
The latest financial statements of Suncross Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Suncross Pharmaceuticals is 23ABKCS9344R1ZG, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Suncross Pharmaceuticals is U46497MP2023PTC065990. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suncross Pharmaceuticals was incorporated on 29 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.
Poornima Dwivedi was appointed as Additional Director on 28 Aug 2025. Shiv Shankar Gupta was appointed as Additional Director on 28 Aug 2025. Vidyakant Dwivedi ceased to be Director on 28 Aug 2025. Suncross Pharmaceuticals has 6 board changes on record in total.
The registered office of Suncross Pharmaceuticals is at Plot No. 101 Second Floor Flat No 201, Limbodi, Indore, Madhya Pradesh, India – 452001.
Suncross Pharmaceuticals can be reached at its registered office: Plot No. 101 Second Floor Flat No 201, Limbodi, Indore, Madhya Pradesh, India – 452001.
Suncross Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.

